Skip to main content
TipRanks
Go Ultimate75% OFF

Bioxcel Therapeutics (BTAIQ) Ownership - Who Owns Bioxcel Therapeutics?

1,940 Followers

Bioxcel Therapeutics (BTAIQ) Ownership Overview

  • 2.75% Insiders
  • 3.61% Mutual Funds
  • 0.07% Other Institutional Investors
  • 93.57% Public Companies and Individual Investors

The ownership structure of Bioxcel Therapeutics (BTAIQ) stock is a mix of institutional, retail, and individual investors. Approximately 3.68% of the company’s stock is owned by Institutional Investors, 2.75% is owned by Insiders, and 93.57% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

BTAIQ top shareholders
Holder# of SharesType% HoldingValue
Vanguard Index Funds886,909Institution2.83%9,756
Vimal Mehta550,285Insider1.76%6,053
Peter Mueller209,795Insider0.67%2,308
Fidelity Concord Street Trust199,798Institution0.64%2,198
BlackRock, Inc.179,433Institution0.57%1,974
Hc Capital Trust29,713Institution0.09%327
Javier Rodriguez26,838Insider0.09%295
Richard Steinhart26,335Insider0.08%290
Frank Yocca26,210Insider0.08%288
Mack David J.20,317Insider0.06%223

Top Mutual Fund Holders

BTAIQ top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds886,909Institution2.83%9,756
Fidelity Concord Street Trust199,798Institution0.64%2,198
Hc Capital Trust29,713Institution0.09%327
Tiaa-cref Funds14,808Institution0.05%163
Northern Funds6,609Institution0.02%73
Victory Portfolios Iii2,135Institution<0.01%23
John Hancock Variable Insurance Trust651Institution<0.01%7

FAQ

Who Owns Bioxcel Therapeutics (BTAIQ)?
According to the latest TipRanks data, approximately 3.68% of the company's stock is held by institutional investors, 2.75% is held by insiders, and 93.57% is held by public companies and individual investors.
What percentage of Bioxcel Therapeutics (BTAIQ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.68% of Bioxcel Therapeutics (BTAIQ) stock is held by institutional investors: 3.61% by mutual funds and 0.07% by other institutional investors.
What percentage of Bioxcel Therapeutics (BTAIQ) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.57% of Bioxcel Therapeutics (BTAIQ) stock is held by public companies and individual investors.
Who owns the most shares of Bioxcel Therapeutics (BTAIQ)?
VANGUARD INDEX FUNDS owns the most shares of Bioxcel Therapeutics (BTAIQ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.